BIO-TECHNE Corp (TECH) financials

BIO-TECHNE Corp (TECH) revenue, EBIT and EBITDA, earnings per share, free cash flow, margins, debt and shareholders equity — annual and quarterly history, charted from SEC filings. No account needed.

In fiscal 2026, BIO-TECHNE Corp reported revenue of $1.22B, down 0.4% year over year, net income of $182M, diluted EPS of $1.16 and free cash flow of $263M.

Revenue (fiscal 2026)

$1.22B

Revenue growth (fiscal 2026)

-0.4%

Net income (fiscal 2026)

$182M

Diluted EPS (fiscal 2026)

$1.16

Free cash flow (fiscal 2026)

$263M

BIO-TECHNE Corp files with the U.S. Securities and Exchange Commission under CIK 0000842023, classified as Biological Products, (No Diagnostic Substances).

Explore annual and quarterly revenue, earnings, cash flow, margins, debt and equity from SEC filings.